R.G. Simmonds

679 total citations
20 papers, 452 citations indexed

About

R.G. Simmonds is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging and Organic Chemistry. According to data from OpenAlex, R.G. Simmonds has authored 20 papers receiving a total of 452 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 6 papers in Radiology, Nuclear Medicine and Imaging and 4 papers in Organic Chemistry. Recurrent topics in R.G. Simmonds's work include Chemical Synthesis and Analysis (6 papers), Monoclonal and Polyclonal Antibodies Research (6 papers) and HER2/EGFR in Cancer Research (4 papers). R.G. Simmonds is often cited by papers focused on Chemical Synthesis and Analysis (6 papers), Monoclonal and Polyclonal Antibodies Research (6 papers) and HER2/EGFR in Cancer Research (4 papers). R.G. Simmonds collaborates with scholars based in United Kingdom, United States and Canada. R.G. Simmonds's co-authors include G. F. Rowland, C S Woodhouse, James R. Johnson, C.E. Newman, C. H. J. Ford, R W Baldwin, M. J. Embleton, Elizabeth R. Jacobs, William K. Smith and David E. Tupper and has published in prestigious journals such as Nature, British Journal of Cancer and Tetrahedron.

In The Last Decade

R.G. Simmonds

19 papers receiving 410 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
R.G. Simmonds United Kingdom	12	213	182	155	102	74	20	452
Antje Rottmann Germany	12	79 0.4×	173 1.0×	108 0.7×	25 0.2×	74 1.0×	29	654
K.A. BIEDERMANN United States	7	87 0.4×	506 2.8×	199 1.3×	108 1.1×	50 0.7×	9	822
Eileen S. Walsh United States	17	59 0.3×	508 2.8×	208 1.3×	91 0.9×	133 1.8×	20	844
Rachana Ohri United States	9	204 1.0×	208 1.1×	195 1.3×	47 0.5×	167 2.3×	11	479
Czesław Radzikowski Poland	14	58 0.3×	338 1.9×	99 0.6×	70 0.7×	130 1.8×	28	533
Luc Roumen Netherlands	16	167 0.8×	464 2.5×	239 1.5×	165 1.6×	80 1.1×	21	736
Johan Broddefalk Sweden	13	209 1.0×	381 2.1×	58 0.4×	193 1.9×	273 3.7×	18	664
Samuel Brooks United States	8	34 0.2×	249 1.4×	153 1.0×	35 0.3×	31 0.4×	11	599
Mary Zoeckler United States	11	53 0.2×	180 1.0×	203 1.3×	22 0.2×	72 1.0×	14	485
Dawn Dufield United States	13	82 0.4×	291 1.6×	58 0.4×	97 1.0×	21 0.3×	21	603

Countries citing papers authored by R.G. Simmonds

Since Specialization

Citations

This map shows the geographic impact of R.G. Simmonds's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R.G. Simmonds with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R.G. Simmonds more than expected).

Fields of papers citing papers by R.G. Simmonds

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R.G. Simmonds. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R.G. Simmonds. The network helps show where R.G. Simmonds may publish in the future.

Co-authorship network of co-authors of R.G. Simmonds

This figure shows the co-authorship network connecting the top 25 collaborators of R.G. Simmonds. A scholar is included among the top collaborators of R.G. Simmonds based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R.G. Simmonds. R.G. Simmonds is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Simmonds, R.G., et al.. (2001). Non-nucleophilic base (KHMDS) mediated nucleophilic conversion of Merrifield resin into aminomethyl resin. Tetrahedron Letters. 42(32). 5517–5519. 3 indexed citations

Simmonds, R.G.. (1996). Use of the Hmb backbone‐protecting group in the synthesis of difficult sequences. International journal of peptide & protein research. 47(1-2). 36–41. 29 indexed citations

Simmonds, R.G., David E. Tupper, & John E. Harris. (1994). Synthesis of disulfide‐bridged fragments of ω‐conotoxins GVIA and MVIIA. International journal of peptide & protein research. 43(4). 363–366. 16 indexed citations

Simmonds, R.G., David E. Tupper, & John E. Harris. (1994). Synthesis of disulfide-bridged fragments of omega-conotoxins GVIA and MVIIA. Use of Npys as a protecting/activating group for cysteine in Fmoc syntheses.. PubMed. 43(4). 363–6. 11 indexed citations

Simmonds, R.G., et al.. (1988). Purification of mouse haptoglobin by antibody affinity chromatography and development of an ELISA to measure serum haptoglobin levels. Journal of Immunological Methods. 108(1-2). 53–59. 9 indexed citations

Rowland, G. F., et al.. (1986). Drug localisation and growth inhibition studies of vindesine-monoclonal anti-CEA conjugates in a human tumour xenograft. Cancer Immunology Immunotherapy. 21(3). 183–7. 34 indexed citations

Rowland, G. F., R W Baldwin, Joseph P. Brown, et al.. (1985). Antitumor properties of vindesine-monoclonal antibody conjugates. Cancer Immunology Immunotherapy. 19(1). 1–7. 60 indexed citations

Embleton, M. J., et al.. (1984). Experience in the preparation and experimental use of immunocytostatics.. PubMed. 108–12. 1 indexed citations

Embleton, M. J., et al.. (1983). Selective cytotoxicity against human tumour cells by a vindesine-monoclonal antibody conjugate. British Journal of Cancer. 47(1). 43–49. 58 indexed citations

10.

Ford, C. H. J., C.E. Newman, James R. Johnson, et al.. (1983). Localisation and toxicity study of a vindesine-anti-CEA conjugate in patients with advanced cancer. British Journal of Cancer. 47(1). 35–42. 81 indexed citations

11.

Simmonds, R.G., et al.. (1982). 3-phenylazo-4-hydroxyphenylisothiocyanates: Reagents for Efficient Haptenation of immunoglobulin and other carrier molecules. Journal of Immunological Methods. 54(1). 23–30. 3 indexed citations

12.

Clark, Natalie, R. M. E. Parkhouse, & R.G. Simmonds. (1982). Positive and negative selection of cells by hapten-modified antibodies. Journal of Immunological Methods. 51(2). 167–170. 5 indexed citations

13.

Johnson, James R., C. H. J. Ford, C.E. Newman, et al.. (1981). A vindesine-anti-CEA conjugate cytotoxic for human cancer cells in vitro. British Journal of Cancer. 44(3). 472–475. 21 indexed citations

14.

Meade, Christopher J., et al.. (1981). The relationship between hyperglycaemia and renal immune complex deposition in mice with inherited diabetes.. PubMed. 43(1). 109–20. 11 indexed citations

15.

Simmonds, R.G., et al.. (1980). Stereospecific inversion of (R)-(−)-benoxaprofen in rat and man. European Journal of Drug Metabolism and Pharmacokinetics. 5(3). 169–172. 59 indexed citations

16.

Evans, Timothy J., et al.. (1975). Preparation and some reactions of 2,2-diaryl-2H-imidazole 1-oxides. Journal of the Chemical Society Perkin Transactions 1. 1803–1803. 13 indexed citations

17.

Simmonds, R.G., et al.. (1972). Synthesis of some phenanthridone derivatives. Journal of Heterocyclic Chemistry. 9(3). 475–480. 3 indexed citations

18.

Barker, S. A., M.H.B. Hayes, R.G. Simmonds, & M. Stacey. (1967). Studies on soil polysaccharides I.. Carbohydrate Research. 5(1). 13–24. 21 indexed citations

19.

Barker, S. A., et al.. (1966). Aryl 2-acetamido-2-deoxy-β-D-glucopyranosides —potential anti-inflammatory agetns. Tetrahedron. 22. 611–619. 6 indexed citations

20.

Barker, S. A., Paul Finch, M.H.B. Hayes, R.G. Simmonds, & M. Stacey. (1965). Isolation and Preliminary Characterization of Soil Polysaccharides. Nature. 205(4966). 68–69. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact